Ceylon Hospitals PLC (CHL)

Currency in LKR
116.00
-0.25(-0.22%)
Closed·
Showing Ceylon Hospitals historical data. For real-time data please try another search
Day's Range
116.00120.00
52 wk Range
110.00132.00
Key Statistics
Bid/Ask
130.25 / 132.00
Prev. Close
116.25
Open
120
Day's Range
116-120
52 wk Range
110-132
Volume
157
Average Volume (3m)
540
1-Year Change
-3.33%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Ceylon Hospitals PLC Company Profile

Ceylon Hospitals PLC provides healthcare services under the Durdans brand in Sri Lanka. It offers healthcare services in the areas of cardiology, neurology, orthopedics, gynecology and obstetrics, ophthalmology, urology, endocrinology, general surgery, pediatrics, gastroenterology, dermatology, plastic surgery and cosmetic procedures, nephrology, dietetics and nutrition, physiotherapy, health screening, and radiology and imaging services. The company also provides accident and emergency care; accommodation and general; ambulance and outpatient; blood bank; intensive and critical care; pharmacy; home medical; corporate; COVID-19; and ears, nose, and throat care services. In addition, it operates wellness center; dental and vaccination clinics; operating theatres; clinical laboratory; and audiology, and speech and learning centers, as well as provides preventive cardiac and cardiac surgical care services. Further, the company supplies molecular biological, biochemical, biotechnological, test kits, equipment, and accessories for molecular diagnostics and research. Ceylon Hospitals PLC was founded in 1939 and is based in Colombo, Sri Lanka. Ceylon Hospitals PLC is a subsidiary of Durdans Management Services Ltd.

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 15.84%
Dividend Yield
2.36%
Industry Median -
Annualised payout
4.00
Paid annually
5-Years Growth
+12.70%
Growth Streak

Earnings

Latest Release
Jun 01, 2025
EPS / Forecast
4.33 / --
Revenue / Forecast
2.54B / --
EPS Revisions
Last 90 days

CHL Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.